Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review
吉非替尼联合贝伐珠单抗治疗在奥希替尼治疗后出现获得性C797S突变的非小细胞肺癌患者中取得持久临床获益:病例报告及文献综述
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1673836
Tan, Yuping; Dong, Meng; Li, Xi; Li, Wenbo; Xiong, Fei; Bao, Weidong; Dai, Yongzhou; Yue, Linjun; Liu, Yuan